𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paraoxonase 2 (PON2) polymorphisms and Parkinson's disease

✍ Scribed by Lucio G. Costa; Samir N. Kelada; Paola Costa-Mallen; Fred M. Farin; Hannah A. Viernes; Terri Smith Weller; Gary M. Franklin; William T. Longstreth; Philip D. Swanson; Harvey Checkoway; Clement E. Furlong


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
743 KB
Volume
34
Category
Article
ISSN
0893-6609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cyclooxygenase-2 polymorphisms in Parkin
✍ Anna HΓ₯kansson; Olle Bergman; Cecilia Chrapkowska; Lars Westberg; Andrea Carmine πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 61 KB
Cyclooxygenase-2 polymorphisms in Parkin
✍ Anna HΓ₯kansson; Olle Bergman; Cecilia Chrapkowska; Lars Westberg; Andrea Carmine πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 32 KB
Further evidence for an association of t
✍ Andrea Carmine; Silvia Buervenich; Olof Sydow; Maria Anvret; Lars Olson πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 1 views

Paraoxonase1 (PON1) is an arylesterase mainly expressed in the liver that hydrolyzes organophosphates such as pesticides, reported risk factors for Parkinson's disease (PD), and other neurotoxins. A Leu-Met 54 polymorphism in the gene for PON1-affecting enzyme activity was recently shown, employing